CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 21, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter of 2006 on Wednesday, July 26, 2006, before the U.S. financial markets open.
